Migraine: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (fix ref) |
Notjusttired (talk | contribs) (expand prevention and treatment) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Migraine''' headaches commonly occur in people with [[ME/CFS]]. In a 2011 study by Ravindran, et al, migraine headaches were found in 84%, and tension-type headaches in 81% of a cohort of [[Chronic fatigue syndrome|CFS]] patients.<ref name=":0" /> This compared to 5% and 45%, respectively, in a cohort of healthy controls.<ref name=":0" /> | '''Migraine''' headaches commonly occur in people with [[ME/CFS]]. In a 2011 study by Ravindran, et al, migraine headaches were found in 84%, and tension-type headaches in 81% of a cohort of [[Chronic fatigue syndrome|CFS]] patients.<ref name=":0" /> This compared to 5% and 45%, respectively, in a cohort of healthy controls.<ref name=":0" /> | ||
== | ==Symptoms== | ||
Migraine without aura is defined by the following diagnostic criteria outlined in''The International Classification Of Headache Disorders, | '''Migraine without aura''' is defined by the following diagnostic criteria outlined in ''The International Classification Of Headache Disorders, 3rd edition'': | ||
===Migraine without aura diagnostic criteria=== | |||
<ol style="list-style-type:upper-alpha"><li> At least '''five''' headache attacks that</li> | |||
<li> Last 4–72 hours without successful treatment</li> | |||
<li> Headaches have at least '''two''' of the following four characteristics:</li> | |||
<ol><li> unilateral location;</li> | |||
<li> pulsating quality;</li> | |||
<li> moderate to severe pain intensity; and</li> | |||
<li> aggravation by or causing avoidance of routine physical activity.</li></ol> | |||
<li> During the headaches at least '''one''' of the following:</li> | |||
<ol><li> [[nausea]] and/or vomiting</li> | |||
<li> [[photophobia]] and phonophobia (avoidance of loud noises)</li></ol> | |||
<li> Not better accounted for by another ICHD-3 diagnosis.</li> | |||
</ol> | |||
:Migraines without aura may also be called '''common migraine'<nowiki/>'' or '''''<nowiki/>''hemicrania simplex''.<ref name="ICHD-3">{{Cite journal|last=Headache Classification Committee of the International Headache Society|date=2018|title=The International Classification of Headache Disorders|edition=3rd|url=https://doi.org/10.1177/0333102417738202|journal=Cephalalgia|language=en|volume=38|issue=1|pages=1–211|doi=10.1177/0333102417738202|issn=0333-1024}}</ref> | |||
==Migraines in ME/CFS== | ==Migraines in ME/CFS== | ||
Migraines is one of several illnesses or conditions experienced alongside of ME/CFS.<ref>{{Cite web|url=https://ammes.org/overlapping-conditions/|title=Overlapping Conditions – American ME and CFS Society|website=ammes.org|language=en-US|access-date=2018-08-12}}</ref><br > | Migraines is one of several illnesses or conditions experienced alongside of ME/CFS.<ref>{{Cite web|url=https://ammes.org/overlapping-conditions/|title=Overlapping Conditions – American ME and CFS Society|website=ammes.org|language=en-US|access-date=2018-08-12}}</ref><br> | ||
The [[Canadian Consensus Criteria]] recognizes migraines in the [[:Category:Neurological signs and symptoms |possible neurological symptoms]] of [[ME/CFS]]. | The [[Canadian Consensus Criteria]] recognizes migraines in the [[:Category:Neurological signs and symptoms |possible neurological symptoms]] of [[ME/CFS]]. | ||
| Line 12: | Line 28: | ||
==Potential treatments== | ==Potential treatments== | ||
*[[Sumatriptan]], | Migraine treatment consists of: | ||
* | *Abortive treatments, that aim to stop a migraine attack or reduce the symptoms | ||
*Prevention, which aims to reduce how often migraines occur and their intensity | |||
=== Migraine attack treatments === | |||
*[[:Category:Triptans|Triptans]], e.g. [[Sumatriptan]], brand name Imitrex (13 out of 14 newly diagnosed migraine subjects responded to sumatriptan in one [[Chronic fatigue syndrome|CFS]] patient cohort)<ref name=":0" /> or [[zomitriptan]], brand name Zomig<ref>{{Cite web|url=https://www.drugs.com/health-guide/migraine.html|title=Migraine Guide: Causes, Symptoms and Treatment Options|website=Drugs.com|language=en|access-date=2021-10-12}}</ref> | |||
*Small molecule [[:Category:CGRP antagonists|CGRP antagonists]], known as [[:Category:Gepants|gepants]], which are the newest group of migraine drugs<ref name=":1">{{Cite journal|last=Negro|first=Andrea|author-link=|last2=Martelletti|first2=Paolo|author-link2=|last3=|first3=|author-link3=|last4=|first4=|author-link4=|last5=|first5=|author-link5=|last6=|first6=|author-link6=|last7=|first7=|last8=|first8=|date=Jun 2019|title=Gepants for the treatment of migraine|url=https://pubmed.ncbi.nlm.nih.gov/31081399/|journal=Expert Opinion on Investigational Drugs|volume=28|issue=6|pages=555–567|doi=10.1080/13543784.2019.1618830|issn=1744-7658|pmc=|pmid=31081399|access-date=|quote=|via=}}</ref> | |||
*General pain medications, which are sometimes combined, for example [[acetaminophen]] and naproxen | |||
=== Migraine prevention === | |||
*[[Migraine elimination diet|Migraine elimination diets]], which rely on identifying particular foods, drinks or additives that trigger migraines, for example avoiding the consumption of [[nitrates]] and [[tyramine]] | |||
*CGRP antagonists, particularly [[Calcitonin gene-related peptide monoclonal antibody|CGRP monoclonal antibodies]] but possibly some gepants<ref name=":1" /> | |||
*Drugs developed for other uses that are known to reduce migraines, including propranolol, [[amitriptyline]] (Elavil), [[topiramate]] (Topamax) or botulinum toxin type A (Botox injections)<ref name=":1" /> | |||
*Acupuncture<ref>{{Cite web|url=https://www.nhs.uk/conditions/migraine/prevention/|title=Migraine - Prevention|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=2017-10-23|website=[[National Health Service]]|language=en|archive-url=|archive-date=|url-status=|access-date=2021-10-12}}</ref> | |||
*[[Daith piercing]]<ref>{{Cite journal|last=Cascio Rizzo|first=Angelo|last2=Paolucci|first2=Matteo|last3=Altavilla|first3=Riccardo|last4=Brunelli|first4=Nicoletta|last5=Assenza|first5=Federica|last6=Altamura|first6=Claudia|last7=Vernieri|first7=Fabrizio|date=2017|title=Daith Piercing in a Case of Chronic Migraine: A Possible Vagal Modulation|journal=Frontiers in Neurology|language=English|volume=8|pages=|doi=10.3389/fneur.2017.00624|issn=1664-2295|pmc=5711775|pmid=29230190|via=}}</ref> | *[[Daith piercing]]<ref>{{Cite journal|last=Cascio Rizzo|first=Angelo|last2=Paolucci|first2=Matteo|last3=Altavilla|first3=Riccardo|last4=Brunelli|first4=Nicoletta|last5=Assenza|first5=Federica|last6=Altamura|first6=Claudia|last7=Vernieri|first7=Fabrizio|date=2017|title=Daith Piercing in a Case of Chronic Migraine: A Possible Vagal Modulation|journal=Frontiers in Neurology|language=English|volume=8|pages=|doi=10.3389/fneur.2017.00624|issn=1664-2295|pmc=5711775|pmid=29230190|via=}}</ref> | ||
| Line 19: | Line 48: | ||
*2011, Migraine headaches in [[chronic fatigue syndrome]] (CFS): comparison of two prospective cross-sectional studies.<ref name=":0">{{Cite journal|last=Ravindran|first=Murugan K|last2=Zheng|first2=Yin|last3=Timbol|first3=Christian|last4=Merck|first4=Samantha J|last5=Baraniuk|first5=James N|author-link5=James Baraniuk|date=5 Mar 2011|title=Migraine headaches in Chronic Fatigue Syndrome (CFS): Comparison of two prospective cross-sectional studies|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058027/|journal=BMC Neurology|language=en|volume=11|issue=1|pages=|doi=10.1186/1471-2377-11-30|issn=1471-2377|pmc=|pmid=21375763|via=}}</ref> | *2011, Migraine headaches in [[chronic fatigue syndrome]] (CFS): comparison of two prospective cross-sectional studies.<ref name=":0">{{Cite journal|last=Ravindran|first=Murugan K|last2=Zheng|first2=Yin|last3=Timbol|first3=Christian|last4=Merck|first4=Samantha J|last5=Baraniuk|first5=James N|author-link5=James Baraniuk|date=5 Mar 2011|title=Migraine headaches in Chronic Fatigue Syndrome (CFS): Comparison of two prospective cross-sectional studies|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058027/|journal=BMC Neurology|language=en|volume=11|issue=1|pages=|doi=10.1186/1471-2377-11-30|issn=1471-2377|pmc=|pmid=21375763|via=}}</ref> | ||
*2013, Migraine in [[Gulf War Illness|gulf war illness]] and [[chronic fatigue syndrome]]: Prevalence, potential mechanisms, and evaluation.<ref>{{Cite journal|last=Rayhan|first=Rakib U.|last2=Ravindran|first2=Murugan K.|last3=Baraniuk|first3=James N.|date=2013|title=Migraine in gulf war illness and chronic fatigue syndrome: prevalence, potential mechanisms, and evaluation|url=https://www.ncbi.nlm.nih.gov/pubmed/23898301|journal=Frontiers in Physiology|volume=4|pages=181|doi=10.3389/fphys.2013.00181|issn=1664-042X|pmid=23898301|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721020/ (Full Text)] | *2013, Migraine in [[Gulf War Illness|gulf war illness]] and [[chronic fatigue syndrome]]: Prevalence, potential mechanisms, and evaluation.<ref>{{Cite journal|last=Rayhan|first=Rakib U.|last2=Ravindran|first2=Murugan K.|last3=Baraniuk|first3=James N.|date=2013|title=Migraine in gulf war illness and chronic fatigue syndrome: prevalence, potential mechanisms, and evaluation|url=https://www.ncbi.nlm.nih.gov/pubmed/23898301|journal=Frontiers in Physiology|volume=4|pages=181|doi=10.3389/fphys.2013.00181|issn=1664-042X|pmid=23898301|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721020/ (Full Text)] | ||
*2016, Migraines Are Correlated with Higher Levels of Nitrate-, Nitrite-, and Nitric Oxide-Reducing Oral Microbes in the [[American Gut Project]] Cohort | *2016, Migraines Are Correlated with Higher Levels of Nitrate-, Nitrite-, and Nitric Oxide-Reducing Oral Microbes in the [[American Gut Project]] Cohort<ref>{{Cite journal|last=Gonzalez|first=Antonio|last2=Hyde|first2=Embriette|last3=Sangwan|first3=Naseer|last4=Gilbert|first4=Jack A.|last5=Virre|first5=Erik|last6=Knight|first6=Rob|date=Oct 18, 2016|title=Migraines Are Correlated with Higher Levels of Nitrate-, Nitrite-, and Nitric Oxide-Reducing Oral Microbes in the American Gut Project Cohort|url=https://msystems.asm.org/content/msys/1/5/e00105-16.full.pdf|journal=American Society for Microbiology|volume=1|issue=5|pages=|via=}}</ref> [https://msystems.asm.org/content/msys/1/5/e00105-16.full.pdf (Full Text)] | ||
== See also == | == See also == | ||
Revision as of 23:03, October 12, 2021
Migraine headaches commonly occur in people with ME/CFS. In a 2011 study by Ravindran, et al, migraine headaches were found in 84%, and tension-type headaches in 81% of a cohort of CFS patients.[1] This compared to 5% and 45%, respectively, in a cohort of healthy controls.[1]
Symptoms[edit | edit source]
Migraine without aura is defined by the following diagnostic criteria outlined in The International Classification Of Headache Disorders, 3rd edition:
Migraine without aura diagnostic criteria[edit | edit source]
- At least five headache attacks that
- Last 4–72 hours without successful treatment
- Headaches have at least two of the following four characteristics:
- unilateral location;
- pulsating quality;
- moderate to severe pain intensity; and
- aggravation by or causing avoidance of routine physical activity.
- During the headaches at least one of the following:
- nausea and/or vomiting
- photophobia and phonophobia (avoidance of loud noises)
- Not better accounted for by another ICHD-3 diagnosis.
- Migraines without aura may also be called common migraine' or hemicrania simplex.[2]
Migraines in ME/CFS[edit | edit source]
Migraines is one of several illnesses or conditions experienced alongside of ME/CFS.[3]
The Canadian Consensus Criteria recognizes migraines in the possible neurological symptoms of ME/CFS.
Possible causes[edit | edit source]
Potential treatments[edit | edit source]
Migraine treatment consists of:
- Abortive treatments, that aim to stop a migraine attack or reduce the symptoms
- Prevention, which aims to reduce how often migraines occur and their intensity
Migraine attack treatments[edit | edit source]
- Triptans, e.g. Sumatriptan, brand name Imitrex (13 out of 14 newly diagnosed migraine subjects responded to sumatriptan in one CFS patient cohort)[1] or zomitriptan, brand name Zomig[4]
- Small molecule CGRP antagonists, known as gepants, which are the newest group of migraine drugs[5]
- General pain medications, which are sometimes combined, for example acetaminophen and naproxen
Migraine prevention[edit | edit source]
- Migraine elimination diets, which rely on identifying particular foods, drinks or additives that trigger migraines, for example avoiding the consumption of nitrates and tyramine
- CGRP antagonists, particularly CGRP monoclonal antibodies but possibly some gepants[5]
- Drugs developed for other uses that are known to reduce migraines, including propranolol, amitriptyline (Elavil), topiramate (Topamax) or botulinum toxin type A (Botox injections)[5]
- Acupuncture[6]
- Daith piercing[7]
Notable studies[edit | edit source]
- 2011, Migraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studies.[1]
- 2013, Migraine in gulf war illness and chronic fatigue syndrome: Prevalence, potential mechanisms, and evaluation.[8] (Full Text)
- 2016, Migraines Are Correlated with Higher Levels of Nitrate-, Nitrite-, and Nitric Oxide-Reducing Oral Microbes in the American Gut Project Cohort[9] (Full Text)
See also[edit | edit source]
Learn more[edit | edit source]
- Oct 18, 2016, Migraines could be caused by gut bacteria, study suggests[10]
- May 19, 2018, The Migraine Drug Explosion Begins: Could Fibromyalgia and ME/CFS Benefit?[11]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 1.3 Ravindran, Murugan K; Zheng, Yin; Timbol, Christian; Merck, Samantha J; Baraniuk, James N (March 5, 2011). "Migraine headaches in Chronic Fatigue Syndrome (CFS): Comparison of two prospective cross-sectional studies". BMC Neurology. 11 (1). doi:10.1186/1471-2377-11-30. ISSN 1471-2377. PMID 21375763.
- ↑ Headache Classification Committee of the International Headache Society (2018). "The International Classification of Headache Disorders". Cephalalgia (3rd ed.). 38 (1): 1–211. doi:10.1177/0333102417738202. ISSN 0333-1024.
- ↑ "Overlapping Conditions – American ME and CFS Society". ammes.org. Retrieved August 12, 2018.
- ↑ "Migraine Guide: Causes, Symptoms and Treatment Options". Drugs.com. Retrieved October 12, 2021.
- ↑ 5.0 5.1 5.2 Negro, Andrea; Martelletti, Paolo (June 2019). "Gepants for the treatment of migraine". Expert Opinion on Investigational Drugs. 28 (6): 555–567. doi:10.1080/13543784.2019.1618830. ISSN 1744-7658. PMID 31081399.
- ↑ "Migraine - Prevention". National Health Service. October 23, 2017. Retrieved October 12, 2021.
- ↑ Cascio Rizzo, Angelo; Paolucci, Matteo; Altavilla, Riccardo; Brunelli, Nicoletta; Assenza, Federica; Altamura, Claudia; Vernieri, Fabrizio (2017). "Daith Piercing in a Case of Chronic Migraine: A Possible Vagal Modulation". Frontiers in Neurology. 8. doi:10.3389/fneur.2017.00624. ISSN 1664-2295. PMC 5711775. PMID 29230190.
- ↑ Rayhan, Rakib U.; Ravindran, Murugan K.; Baraniuk, James N. (2013). "Migraine in gulf war illness and chronic fatigue syndrome: prevalence, potential mechanisms, and evaluation". Frontiers in Physiology. 4: 181. doi:10.3389/fphys.2013.00181. ISSN 1664-042X. PMID 23898301.
- ↑ Gonzalez, Antonio; Hyde, Embriette; Sangwan, Naseer; Gilbert, Jack A.; Virre, Erik; Knight, Rob (October 18, 2016). "Migraines Are Correlated with Higher Levels of Nitrate-, Nitrite-, and Nitric Oxide-Reducing Oral Microbes in the American Gut Project Cohort" (PDF). American Society for Microbiology. 1 (5).
- ↑ Devlin, Hannah (October 18, 2016). "Migraines could be caused by gut bacteria, study suggests". the Guardian. Retrieved August 11, 2018.
- ↑ Johnson, Cort (May 19, 2018). "The Migraine Drug Explosion Begins: Could Fibromyalgia and ME/CFS Benefit? - Health Rising". Health Rising. Retrieved August 11, 2018.
